These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26086105)

  • 1. Network-based approaches for drug response prediction and targeted therapy development in cancer.
    Dorel M; Barillot E; Zinovyev A; Kuperstein I
    Biochem Biophys Res Commun; 2015 Aug; 464(2):386-91. PubMed ID: 26086105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.
    Kubisch J; Türei D; Földvári-Nagy L; Dunai ZA; Zsákai L; Varga M; Vellai T; Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):252-61. PubMed ID: 23810837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systems biology analysis of autophagy in cancer therapy.
    Shi Z; Li CY; Zhao S; Yu Y; An N; Liu YX; Wu CF; Yue BS; Bao JK
    Cancer Lett; 2013 Sep; 337(2):149-60. PubMed ID: 23791881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome network medicine: innovation to overcome huge challenges in cancer therapy.
    Roukos DH
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(2):201-8. PubMed ID: 24318985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
    Singh S
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):1-15. PubMed ID: 25143300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-Oriented Approaches to Anticancer Drug Response.
    Lecca P; Re A
    Methods Mol Biol; 2017; 1513():101-117. PubMed ID: 27807833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mathematical modeling: an essential tool for the study of therapeutic targeting in solid tumors].
    Saidak Z; Giacobbi AS; Morisse MC; Mammeri Y; Galmiche A
    Med Sci (Paris); 2017 Dec; 33(12):1055-1062. PubMed ID: 29261493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of targeted therapies in cancer: opportunities and challenges in the clinic.
    Santhosh S; Kumar P; Ramprasad V; Chaudhuri A
    Future Oncol; 2015; 11(2):279-93. PubMed ID: 25591839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-related networks: a help to understand, predict and change malignant transformation.
    Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectifying cancer drug discovery through network pharmacology.
    Azmi AS; Mohammad RM
    Future Med Chem; 2014 Apr; 6(5):529-39. PubMed ID: 24649956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback regulation in cell signalling: Lessons for cancer therapeutics.
    Nguyen LK; Kholodenko BN
    Semin Cell Dev Biol; 2016 Feb; 50():85-94. PubMed ID: 26481970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.
    Sarkar FH
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):3-10. PubMed ID: 26228733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
    Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
    Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
    Perego P; Cossa G; Zuco V; Zunino F
    Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.